Additionally, the restoration of G6PC is likely to lead to an increase in blood glucose, which, in turn, increases the risk of diabetes, etc. The dysregulation of G6P is a hallmark of abnormal metabolic diseases including NAFLD, and combining restoration of G6PC with other interventions might provide novel therapeutic strategies for the treatment of NAFLD. The gene discussed is G6PC1; the disease is Other metabolic disease.